✦ LIBER ✦

Stage IV breast cancer in the era of targeted therapy : Does surgery of the primary tumor matter?

✍ Scribed by Heather B. Neuman; Mary Morrogh; Mithat Gonen; Kimberly J. Van Zee; Monica Morrow; Tari A. King

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 156 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24873

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gastric GI stromal tumors (GISTs): The r

Gastric GI stromal tumors (GISTs): The role of surgery in the era of targeted therapy

✍ Michael C. Heinrich; Christopher L. Corless 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Surgical resection of the primary tumor

Surgical resection of the primary tumor in stage IV breast cancer patients: Is a randomized, controlled trial imperative or too costly?

✍ Ryan C. Fields; Julie A. Margenthaler 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB

Irradiation of the tumor bed alone after

Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy

✍ Vicini, Frank; Kini, Vijay R.; Chen, Peter; Horwitz, Eric; Gustafson, Gary; Beni 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Backgrounds and Objectives: We present the interim findings of our in-house protocol treating the tumor bed alone after lumpectomy with low-dose-rate (LDR) interstitial brachytherapy in selected patients with early-stage breast cancer treated with breast conserving therapy (BCT). Methods: From

The use of molecular assays to establish

The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy

✍ Frank A. Vicini; J. Vito Antonucci; Neal Goldstein; Michelle Wallace; Larry Kest 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

## Abstract ## BACKGROUND. Results from numerous trials have indicated that breast‐conserving therapy (BCT) produces outcomes equivalent to those produced by mastectomy in terms of both locoregional control and survival. However, conservative treatment has resulted in the dilemma of how best to ad

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views